Senior insider sale
ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$1.15M
3.83K shares
What this filing means
PYOTT DAVID E I plans to sell 3.83K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $1.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001969223-26-000618
Director
Since Jul 2019
3.83K
Shares to sell
$1.15M
Approx. market value
3.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
6/1/2026
3.83KTotal acquired3.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Exercise of stock options Cash | 3.83K | — |
| Total | 3.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.83K
Market value
$1.15M
6/1/2026
Total
Units
3.83K
Value
$1.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/1/2026 | 3.83K | $1.15M | NASDAQ | Planned |
| Total | 3.83K | $1.15M | ||